W. Jeff Edenfield
About
In The Last Decade
W. Jeff Edenfield
5 papers receiving 874 citations
Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 758
- Pulmonary and Respiratory Medicine 300
- Immunology 278
- Cancer Research 175
- Molecular Biology 117
Countries citing papers authored by W. Jeff Edenfield
This map shows the geographic impact of W. Jeff Edenfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Jeff Edenfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Jeff Edenfield more than expected).
Fields of papers citing papers by W. Jeff Edenfield
This network shows the impact of papers produced by W. Jeff Edenfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Jeff Edenfield. The network helps show where W. Jeff Edenfield may publish in the future.
Co-authorship network of co-authors of W. Jeff Edenfield
This figure shows the co-authorship network connecting the top 25 collaborators of W. Jeff Edenfield. A scholar is included among the top collaborators of W. Jeff Edenfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Jeff Edenfield. W. Jeff Edenfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study breakdown → | 581 |
| 3 | 225 | |
| 4 | 39 | |
| 5 | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.